Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Hasbro Lifts Outlook as Quarterly Profit, Revenue Rise (WSJ EN) +++ HASBRO Aktie -5,34%

MEDPACE Aktie

 >MEDPACE Aktienkurs 
556 EUR    +17.9%    (Tradegate)
Ask: 561.8 EUR / 6 Stück
Bid: 556 EUR / 6 Stück
Tagesumsatz: 24 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
MEDPACE Aktie über LYNX handeln
>MEDPACE Performance
1 Woche: +3,8%
1 Monat: +9,7%
3 Monate: +13,4%
6 Monate: +86,5%
1 Jahr: +52,8%
laufendes Jahr: +42,7%
>MEDPACE Aktie
Name:  MEDPACE HOLDINGS DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US58506Q1094 / A2APTV
Symbol/ Ticker:  01P (Frankfurt) / MEDP (NASDAQ)
Kürzel:  FRA:01P, ETR:01P, 01P:GR, NASDAQ:MEDP
Index:  -
Webseite:  https://www.medpace.com/
Profil:  Medpace Holdings Inc. is a prominent entity in the..
>Volltext..
Marktkapitalisierung:  13201.91 Mio. EUR
Unternehmenswert:  13289.71 Mio. EUR
Umsatz:  1922.16 Mio. EUR
EBITDA:  436.21 Mio. EUR
Nettogewinn:  360.26 Mio. EUR
Gewinn je Aktie:  11.9 EUR
Schulden:  129.04 Mio. EUR
Liquide Mittel:  39.9 Mio. EUR
Operativer Cashflow:  528.9 Mio. EUR
Bargeldquote:  0.04
Umsatzwachstum:  -0.04%
Gewinnwachstum:  11.98%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  MEDPACE
Letzte Datenerhebung:  23.10.25
>MEDPACE Kennzahlen
Aktien/ Unternehmen:
Aktien: 28.09 Mio. St.
Frei handelbar: 80.88%
Rückkaufquote: 6.84%
Mitarbeiter: 5900
Umsatz/Mitarb.: 0.31 Mio. EUR
Analysten:
Analystenrating: Sell
Kursziel: -27.18%
Bewertung:
KGV: 46.15
KGV lG: 43.5
KUV: 7.1
KBV: 100.88
PEG-Ratio: 1.53
EV/EBITDA: 30.47
Rentabilität:
Bruttomarge: 30.32%
Gewinnmarge: 18.74%
Operative Marge: 21.4%
Managementeffizenz:
Gesamtkaprendite: 23.96%
Eigenkaprendite: 89.38%
>MEDPACE Peer Group

Es sind 597 Aktien bekannt.
 
23.10.25 - 07:00
VTYX, MEDP, INBX Jump After Hours On Key Updates (RTTNews)
 
Biotech stocks surged in after-hours trading on Wednesday, October 22, led by Ventyx Biosciences, which soared over 88% on positive Phase 2 data. A mix of earnings updates, clinical news, and investor interest lifted several names across the sector, including Medpace, Inhibrx, and Acumen Pharmaceuticals. Here's a look at the biggest movers....
23.10.25 - 01:00
Medpace (MEDP) Beats Q3 Earnings and Revenue Estimates (Zacks)
 
Medpace (MEDP) delivered earnings and revenue surprises of +10.29% and +3.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...
22.10.25 - 23:45
Medpace surges on boost to 2025 guidance, Q3 beats (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
22.10.25 - 23:18
Medpace-Aktie: Quartalszahlen sorgen für Kurssprung (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
22.10.25 - 23:01
Medpace shares soar on blowout Q3 results, solid 2025 outlook (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
22.10.25 - 22:24
Medpace GAAP EPS of $3.86 beats by $0.34, revenue of $659.9M beats by $18.92M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
22.10.25 - 22:21
Medpace Holdings, Inc. Reports Third Quarter 2025 Results (Business Wire)
 
Revenue of $659.9 million in the third quarter of 2025 increased 23.7% from revenue of $533.3 million for the comparable prior-year period, representing a backlog conversion rate of 23.0%. Net new business awards were $789.6 million in the third quarter of 2025, representing an increase of 47.9% from net new business awards of $533.7 million for the comparable prior-year period, which resulted in a net book-to-bill ratio of 1.20x. Third quarter of 2025 GAAP net income was $111.1 million, or $3.86 per diluted share, versus GAAP net income of $96.4 million, or $3.01 per diluted share, for the comparable prior-year period. Net income margin was 16.8% and 18.1% for the third quarter of 2025 and 2024, respectively. EBITDA was $148.4 million for the third quarter of 2025, an increase of 24.9% from EBITDA of $118.8 million for the comparable prior-year period, resulting in an EBITDA margin of 22.5%. CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial resul...
17.10.25 - 01:45
Medpace (MEDP) Rises As Market Takes a Dip: Key Facts (Zacks)
 
Medpace (MEDP) concluded the recent trading session at $521.21, signifying a +1.34% move from its prior day's close....
15.10.25 - 17:30
Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week′s Release (Zacks)
 
Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
11.10.25 - 01:45
Medpace (MEDP) Dips More Than Broader Market: What You Should Know (Zacks)
 
Medpace (MEDP) closed the most recent trading day at $501.22, moving 3.37% from the previous trading session....
09.10.25 - 19:45
Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report? (Zacks)
 
Medpace (MEDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report....
03.10.25 - 01:45
Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors (Zacks)
 
Medpace (MEDP) closed at $536.17 in the latest trading session, marking a -1.42% move from the prior day....
02.10.25 - 15:09
Life science tools Q3 preview: Barclays ups Charles River, downgrades Medpace (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
26.09.25 - 01:45
Medpace (MEDP) Dips More Than Broader Market: What You Should Know (Zacks)
 
In the most recent trading session, Medpace (MEDP) closed at $487.95, indicating a -1.88% shift from the previous trading day....
23.09.25 - 22:06
Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025 (Business Wire)
 
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2025 financial results after the market close on Wednesday, October 22, 2025. The Company will host a conference call the following morning, Thursday, October 23, 2025, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended you join 10 minutes prior to the event start. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique PIN that can be used to access the call. To access the conference call via webcast, visit the “Investors” section of Medpace's website at investor.medpace.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. A supplemental slide...
16.09.25 - 01:45
Why Medpace (MEDP) Outpaced the Stock Market Today (Zacks)
 
Medpace (MEDP) reached $496.41 at the closing of the latest trading day, reflecting a +1.18% change compared to its last close....
12.09.25 - 11:30
The Zacks Analyst Blog Highlights Hasbro, Robinhood Markets, Interactive Brokers, Celsius and Medpace (Zacks)
 
Hasbro, Robinhood, Interactive Brokers, Celsius, and Medpace are top non-tech Nasdaq stocks showing strong growth and robust earnings potential in 2025....
09.09.25 - 02:45
Medpace (MEDP) Outpaces Stock Market Gains: What You Should Know (Zacks)
 
The latest trading day saw Medpace (MEDP) settling at $492.09, representing a +1.05% change from its previous close....
06.09.25 - 00:01
Insiderhandel: Exec. VP, Operations verkauft Aktien von Medpace Holdings im Wert von 4800000 USD (Insiderkauf)
 
Burwig, Susan E. - Vorstand - Tag der Transaktion: 2025-09-03...
03.09.25 - 23:01
Insiderhandel: CEO verkauft Aktien von Medpace Holdings im Wert von 17225676 USD (Insiderkauf)
 
Troendle, August J. - Vorstand - Tag der Transaktion: 2025-08-29...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein Tormann muß Ruhe ausstrahlen, er muß nur aufpassen, daß er dabei nicht einschläft. - Sepp Maier
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!